Complete hormonal blockade versus epirubicin-based chemotherapy in premenopausal, one to three node-positive, and hormone-receptor positive, early breast cancer patients: 7-year follow-up results of French Adjuvant Study Group 06 randomised trial.
暂无分享,去创建一个
J. Bonneterre | A. Monnier | P. Fumoleau | P. Fargeot | P. Kerbrat | P. Chollet | D. Serin | H. Roché | P. Clavère | M. Goudier | J. Guastalla